-
2
-
-
0033779701
-
Calcineurin: Form and function
-
Rusnak F, Mertz P. Calcineurin: form and function. Physiol Rev 2000; 80:1483-1582.
-
(2000)
Physiol Rev
, vol.80
, pp. 1483-1582
-
-
Rusnak, F.1
Mertz, P.2
-
3
-
-
0036162159
-
Old and new tools to dissect calcineurin's role in pressure-overload cardiac hypertrophy
-
Zhang W. Old and new tools to dissect calcineurin's role in pressure-overload cardiac hypertrophy. Cardiovasc Res 2002; 53:294-303.
-
(2002)
Cardiovasc Res
, vol.53
, pp. 294-303
-
-
Zhang, W.1
-
4
-
-
0033515618
-
Failure of calcineurin inhibitors to prevent pressure-overload left ventricular hypertrophy in rats
-
Zhang W, Kowal RC, Rusnak F, Sikkink RA, Olson EN, Victor RG. Failure of calcineurin inhibitors to prevent pressure-overload left ventricular hypertrophy in rats. Circ Res 1999; 84:722-728.
-
(1999)
Circ Res
, vol.84
, pp. 722-728
-
-
Zhang, W.1
Kowal, R.C.2
Rusnak, F.3
Sikkink, R.A.4
Olson, E.N.5
Victor, R.G.6
-
5
-
-
0033515576
-
Prevention of cardiac hypertrophy by calcineurin inhibition: Hope or hype?
-
Olson EN, Molkentin JD. Prevention of cardiac hypertrophy by calcineurin inhibition: hope or hype? Circ Res 1999; 84:623-632.
-
(1999)
Circ Res
, vol.84
, pp. 623-632
-
-
Olson, E.N.1
Molkentin, J.D.2
-
6
-
-
0033515536
-
Signaling in myocardial hypertrophy: Life after calcineurin?
-
Sugden PH. Signaling in myocardial hypertrophy: life after calcineurin?. Circ Res 1999; 84:633-646.
-
(1999)
Circ Res
, vol.84
, pp. 633-646
-
-
Sugden, P.H.1
-
7
-
-
0033515529
-
Calcineurin inhibition as therapy for cardiac hypertrophy and heart failure: Requiescat in pace?
-
Walsh RA. Calcineurin inhibition as therapy for cardiac hypertrophy and heart failure: requiescat in pace? Circ Res 1999; 84:741-743.
-
(1999)
Circ Res
, vol.84
, pp. 741-743
-
-
Walsh, R.A.1
-
8
-
-
33646699104
-
Effects of combination of irbesartan and perindopril on calcineurin expression and sarcoplasmic reticulum Ca2+-ATPase activity in rat cardiac pressure-overload hypertrophy
-
Jiang QJ, Xu G, Mao FF, Zhu YF. Effects of combination of irbesartan and perindopril on calcineurin expression and sarcoplasmic reticulum Ca2+-ATPase activity in rat cardiac pressure-overload hypertrophy. J Zhejiang Univ Sci B 2006; 7:228-234.
-
(2006)
J Zhejiang Univ Sci B
, vol.7
, pp. 228-234
-
-
Jiang, Q.J.1
Xu, G.2
Mao, F.F.3
Zhu, Y.F.4
-
9
-
-
33645274695
-
L-type calcium channel blocker suppresses calcineurin signal pathway and development of right ventricular hypertrophy
-
Liu CZ, Tan JX, Wang Y, Huang YG, Huang DL. L-type calcium channel blocker suppresses calcineurin signal pathway and development of right ventricular hypertrophy. J Formos Med Assoc 2005; 104:798-803.
-
(2005)
J Formos Med Assoc
, vol.104
, pp. 798-803
-
-
Liu, C.Z.1
Tan, J.X.2
Wang, Y.3
Huang, Y.G.4
Huang, D.L.5
-
10
-
-
0035984393
-
AT1 receptor blockade reduces cardiac calcineurin activity in hypertensive rats
-
Nagata K, Somura F, Obata K, Odashima M, Izawa H, Ichihara S, Nagasaka T, Iwase M, Yamada Y, Nakashima N, Yokota M. AT1 receptor blockade reduces cardiac calcineurin activity in hypertensive rats. Hypertension 2002; 40:168-174.
-
(2002)
Hypertension
, vol.40
, pp. 168-174
-
-
Nagata, K.1
Somura, F.2
Obata, K.3
Odashima, M.4
Izawa, H.5
Ichihara, S.6
Nagasaka, T.7
Iwase, M.8
Yamada, Y.9
Nakashima, N.10
Yokota, M.11
-
11
-
-
38749107036
-
Angiotensin-converting enzyme inhibitor suppresses activation of calcineurin in renovascular hypertensive rats
-
Sheng H, Zhu J, Wu X, Yang D, Zhang J. Angiotensin-converting enzyme inhibitor suppresses activation of calcineurin in renovascular hypertensive rats. Hypertens Res 2007; 30:1247-1254.
-
(2007)
Hypertens Res
, vol.30
, pp. 1247-1254
-
-
Sheng, H.1
Zhu, J.2
Wu, X.3
Yang, D.4
Zhang, J.5
-
12
-
-
18244366406
-
Continuous blockade of L-type Ca2+ channels suppresses activation of calcineurin and development of cardiac hypertrophy in spontaneously hypertensive rats
-
Zou Y, Yamazaki T, Nakagawa K, Yamada H, Iriguchi N, Toko H, Takano H, Akazawa H, Nagai R, Komuro I. Continuous blockade of L-type Ca2+ channels suppresses activation of calcineurin and development of cardiac hypertrophy in spontaneously hypertensive rats. Hypertens Res 2002; 25:117-124.
-
(2002)
Hypertens Res
, vol.25
, pp. 117-124
-
-
Zou, Y.1
Yamazaki, T.2
Nakagawa, K.3
Yamada, H.4
Iriguchi, N.5
Toko, H.6
Takano, H.7
Akazawa, H.8
Nagai, R.9
Komuro, I.10
-
13
-
-
0037065888
-
Calcineurin inhibition attenuates mineralocorticoid-induced cardiac hypertrophy
-
Takeda Y, Yoneda T, Demura M, Usukura M, Mabuchi H. Calcineurin inhibition attenuates mineralocorticoid-induced cardiac hypertrophy. Circulation 2002; 105:677-679.
-
(2002)
Circulation
, vol.105
, pp. 677-679
-
-
Takeda, Y.1
Yoneda, T.2
Demura, M.3
Usukura, M.4
Mabuchi, H.5
-
14
-
-
0034709643
-
Cardiac calcineurin during transition from hypertrophy to heart failure in rats
-
Hayashida W, Kihara Y, Yasaka A, Sasayama S. Cardiac calcineurin during transition from hypertrophy to heart failure in rats. BBRC 2000; 273:347-351.
-
(2000)
BBRC
, vol.273
, pp. 347-351
-
-
Hayashida, W.1
Kihara, Y.2
Yasaka, A.3
Sasayama, S.4
-
15
-
-
0347320747
-
Calcineurin/NFAT coupling participates in pathological, but not physiological, cardiac hypertrophy
-
Wilkins BJ, Dai YS, Bueno OF, Parsons SA, Xu J, Plank DM, Jones F, Kimball TR, Molkentin JD. Calcineurin/NFAT coupling participates in pathological, but not physiological, cardiac hypertrophy. Circ Res 2004; 94:110-118.
-
(2004)
Circ Res
, vol.94
, pp. 110-118
-
-
Wilkins, B.J.1
Dai, Y.S.2
Bueno, O.F.3
Parsons, S.A.4
Xu, J.5
Plank, D.M.6
Jones, F.7
Kimball, T.R.8
Molkentin, J.D.9
-
16
-
-
0034662930
-
Cyclosporine A-induced hypertension involves synapsin in renal sensory nerve endings
-
Zhang W, Li JL, Hosaka M, Janz R, Shelton JM, Albright GM, Richardson JA, Sudhof TC, Victor RG. Cyclosporine A-induced hypertension involves synapsin in renal sensory nerve endings. Proc Natl Acad Sci USA 2000; 97:9765-9770.
-
(2000)
Proc Natl Acad Sci USA
, vol.97
, pp. 9765-9770
-
-
Zhang, W.1
Li, J.L.2
Hosaka, M.3
Janz, R.4
Shelton, J.M.5
Albright, G.M.6
Richardson, J.A.7
Sudhof, T.C.8
Victor, R.G.9
-
17
-
-
0033862768
-
Calcineurin inhibitors cause renal afferent activation in rats: A novel mechanism of cyclosporine-induced hypertension
-
Zhang W, Victor RG. Calcineurin inhibitors cause renal afferent activation in rats: a novel mechanism of cyclosporine-induced hypertension. Am J Hypertens 2000; 13:999-1004.
-
(2000)
Am J Hypertens
, vol.13
, pp. 999-1004
-
-
Zhang, W.1
Victor, R.G.2
-
18
-
-
0030753168
-
Mechanisms of hypertension in cardiac transplantation and the role of cyclosporine
-
Ventura HO, Malik FS, Mehra MR, Stapleton DD, Smart FW. Mechanisms of hypertension in cardiac transplantation and the role of cyclosporine. Curr Opin Cardiol 1997; 12:375-381.
-
(1997)
Curr Opin Cardiol
, vol.12
, pp. 375-381
-
-
Ventura, H.O.1
Malik, F.S.2
Mehra, M.R.3
Stapleton, D.D.4
Smart, F.W.5
-
19
-
-
33646027287
-
Different effects of amlodipine and enalapril on the mitogen-activated protein kinase/extracellular signal-regulated kinase kinase-extracellular signal-regulated kinase pathway for induction of vascular smooth muscle cell differentiation in vivo
-
Umemoto S, Kawahara S, Hashimoto R, Umeji K, Matsuda S, Tanaka M, Kubo M, Matsuzaki M. Different effects of amlodipine and enalapril on the mitogen-activated protein kinase/extracellular signal-regulated kinase kinase-extracellular signal-regulated kinase pathway for induction of vascular smooth muscle cell differentiation in vivo. Hypertens Res 2006; 29:179-186.
-
(2006)
Hypertens Res
, vol.29
, pp. 179-186
-
-
Umemoto, S.1
Kawahara, S.2
Hashimoto, R.3
Umeji, K.4
Matsuda, S.5
Tanaka, M.6
Kubo, M.7
Matsuzaki, M.8
-
20
-
-
58849151764
-
Adenovirus-mediated FKBP12.6 overexpression induces hypertrophy and apoptosis in cultured neonatal cardiomyocytes
-
in press
-
Zhong J, Chen J, Cao T, Wang L, Zhang W, Liu D, Zhu Z. Adenovirus-mediated FKBP12.6 overexpression induces hypertrophy and apoptosis in cultured neonatal cardiomyocytes. Clin Exp Pharmacol Physiol, in press.
-
Clin Exp Pharmacol Physiol
-
-
Zhong, J.1
Chen, J.2
Cao, T.3
Wang, L.4
Zhang, W.5
Liu, D.6
Zhu, Z.7
-
21
-
-
0030999877
-
Aldosterone and dexamethasone stimulate calcineurin activity through a transcription- independent mechanism involving steroid receptor-associated heat shock proteins
-
Tumlin JA, Lea JP, Swanson CE, Smith CL, Edge SS, Someren JS. Aldosterone and dexamethasone stimulate calcineurin activity through a transcription- independent mechanism involving steroid receptor-associated heat shock proteins. J Clin Invest 1997; 99:1217-1223.
-
(1997)
J Clin Invest
, vol.99
, pp. 1217-1223
-
-
Tumlin, J.A.1
Lea, J.P.2
Swanson, C.E.3
Smith, C.L.4
Edge, S.S.5
Someren, J.S.6
-
22
-
-
0033554044
-
Heat shock proteins 70 and 90 increase calcineurin activity in vitro through calmodulin-dependent and independent mechanisms
-
Someren JS, Faber LE, Klein JD, Tumlin JA. Heat shock proteins 70 and 90 increase calcineurin activity in vitro through calmodulin-dependent and independent mechanisms. BBRC 1999; 260:619-625.
-
(1999)
BBRC
, vol.260
, pp. 619-625
-
-
Someren, J.S.1
Faber, L.E.2
Klein, J.D.3
Tumlin, J.A.4
-
23
-
-
0026689952
-
Immunohistochemical and biochemical evidence for a cardiovascular mineralocorticoid receptor
-
Lombes M, Oblin ME, Gasc JM, Baulieu EE, Farman N, Bonvalet JP. Immunohistochemical and biochemical evidence for a cardiovascular mineralocorticoid receptor. Circ Res 1992; 71:503-510.
-
(1992)
Circ Res
, vol.71
, pp. 503-510
-
-
Lombes, M.1
Oblin, M.E.2
Gasc, J.M.3
Baulieu, E.E.4
Farman, N.5
Bonvalet, J.P.6
-
24
-
-
3242737409
-
Aldosterone directly induces myocyte apoptosis through calcineurin-dependent pathways
-
Mano A, Tatsumi T, Shiraishi J, Keira N, Nomura T, Takeda M, Nishikawa S, Yamanaka S, Matoba S, Kobara M, Tanaka H, Shirayama T, Takamatsu T, Nozawa Y, Matsubara H. Aldosterone directly induces myocyte apoptosis through calcineurin-dependent pathways. Circulation 2004; 110:317-323.
-
(2004)
Circulation
, vol.110
, pp. 317-323
-
-
Mano, A.1
Tatsumi, T.2
Shiraishi, J.3
Keira, N.4
Nomura, T.5
Takeda, M.6
Nishikawa, S.7
Yamanaka, S.8
Matoba, S.9
Kobara, M.10
Tanaka, H.11
Shirayama, T.12
Takamatsu, T.13
Nozawa, Y.14
Matsubara, H.15
-
26
-
-
33744497316
-
Hypertension and counter-hypertension mechanisms in giraffes
-
Zhang QG. Hypertension and counter-hypertension mechanisms in giraffes. Cardiovasc Hematol Disord Drug Targets 2006; 6:63-67.
-
(2006)
Cardiovasc Hematol Disord Drug Targets
, vol.6
, pp. 63-67
-
-
Zhang, Q.G.1
-
27
-
-
0023699953
-
Left ventricular hypertrophy in cyclosporine-induced systemic hypertension after cardiac transplantation
-
McKoy RC, Uretsky BF, Kormos R, Hardesty RL, Griffith BP, Salerni R. Left ventricular hypertrophy in cyclosporine-induced systemic hypertension after cardiac transplantation. Am J Cardiol 1988; 62:1140-1142.
-
(1988)
Am J Cardiol
, vol.62
, pp. 1140-1142
-
-
McKoy, R.C.1
Uretsky, B.F.2
Kormos, R.3
Hardesty, R.L.4
Griffith, B.P.5
Salerni, R.6
-
28
-
-
0025233377
-
Effect of systemic hypertension on renal function and left ventricular hypertrophy in heart transplant recipients
-
Farge D, Julien J, Amrein C, Guillemain R, Vulser C, Mihaileanu S, Dreyfus G, Carpentier A. Effect of systemic hypertension on renal function and left ventricular hypertrophy in heart transplant recipients. J Am Coll Cardiol 1990; 15:1095-1101.
-
(1990)
J Am Coll Cardiol
, vol.15
, pp. 1095-1101
-
-
Farge, D.1
Julien, J.2
Amrein, C.3
Guillemain, R.4
Vulser, C.5
Mihaileanu, S.6
Dreyfus, G.7
Carpentier, A.8
-
29
-
-
0026781515
-
Circadian rhythms of heart rate and blood pressure after heart transplantation
-
Dart AM, Yeoh JK, Jennings GL, Cameron JD, Esmore DS. Circadian rhythms of heart rate and blood pressure after heart transplantation. J Heart Lung Transplant 1992; 11:784-792.
-
(1992)
J Heart Lung Transplant
, vol.11
, pp. 784-792
-
-
Dart, A.M.1
Yeoh, J.K.2
Jennings, G.L.3
Cameron, J.D.4
Esmore, D.S.5
-
30
-
-
0028268218
-
Cardiovascular adaptation to cyclosporine-induced hypertension
-
Ventura HO, Lavie CJ, Messerli FH, Valentino V, Smart FW, Stapleton DD, Ochsner JL. Cardiovascular adaptation to cyclosporine-induced hypertension. J Hum Hypertens 1994; 8:233-237.
-
(1994)
J Hum Hypertens
, vol.8
, pp. 233-237
-
-
Ventura, H.O.1
Lavie, C.J.2
Messerli, F.H.3
Valentino, V.4
Smart, F.W.5
Stapleton, D.D.6
Ochsner, J.L.7
-
31
-
-
0028933437
-
Left ventricular mass increases during cardiac allograft vascular rejection
-
Gill EA, Borrego C, Bray BE, Renlund DG, Hammond EH, Gilbert EM. Left ventricular mass increases during cardiac allograft vascular rejection. J Am Coll Cardiol 1995; 25:922-926.
-
(1995)
J Am Coll Cardiol
, vol.25
, pp. 922-926
-
-
Gill, E.A.1
Borrego, C.2
Bray, B.E.3
Renlund, D.G.4
Hammond, E.H.5
Gilbert, E.M.6
-
32
-
-
0030037191
-
Postmortem findings in lung transplant recipients
-
Husain AN, Siddiqui MT, Reddy VB, Yeldandi V, Montoya A, Garrity ER. Postmortem findings in lung transplant recipients. Mod Pathol 1996; 9:752-761.
-
(1996)
Mod Pathol
, vol.9
, pp. 752-761
-
-
Husain, A.N.1
Siddiqui, M.T.2
Reddy, V.B.3
Yeldandi, V.4
Montoya, A.5
Garrity, E.R.6
-
33
-
-
0030811611
-
Assessment of early left ventricular remodeling in orthotopic heart transplant recipients with cine magnetic resonance imaging: Potential mechanisms
-
Globits S, De Marco T, Schwitter J, Sakuma H, O'Sullivan M, Rifkin C, Keith F, Chatterjee K, Parmley WW, Higgins CB. Assessment of early left ventricular remodeling in orthotopic heart transplant recipients with cine magnetic resonance imaging: potential mechanisms. J Heart Lung Transplant 1997; 16:504-510.
-
(1997)
J Heart Lung Transplant
, vol.16
, pp. 504-510
-
-
Globits, S.1
De Marco, T.2
Schwitter, J.3
Sakuma, H.4
O'Sullivan, M.5
Rifkin, C.6
Keith, F.7
Chatterjee, K.8
Parmley, W.W.9
Higgins, C.B.10
-
34
-
-
0032752214
-
Influence of felodipine on left ventricular hypertrophy and systolic function in orthotopic heart transplant recipients: Possible interaction with cyclosporine medication
-
Schwitter J, De Marco T, Globits S, Sakuma H, Klinski C, Chatterjee K, Parmley WW, Higgins CB. Influence of felodipine on left ventricular hypertrophy and systolic function in orthotopic heart transplant recipients: possible interaction with cyclosporine medication. J Heart Lung Transplant 1999; 18:1003-1013.
-
(1999)
J Heart Lung Transplant
, vol.18
, pp. 1003-1013
-
-
Schwitter, J.1
De Marco, T.2
Globits, S.3
Sakuma, H.4
Klinski, C.5
Chatterjee, K.6
Parmley, W.W.7
Higgins, C.B.8
-
35
-
-
0033670171
-
Regression of left ventricular hypertrophy by AT1 receptor blockade in renal transplant recipients
-
Klingbeil AU, Muller HJ, Delles C, Fleischmann E, Schmieder RE. Regression of left ventricular hypertrophy by AT1 receptor blockade in renal transplant recipients. Am J Hypertens 2000; 13:1295-1300.
-
(2000)
Am J Hypertens
, vol.13
, pp. 1295-1300
-
-
Klingbeil, A.U.1
Muller, H.J.2
Delles, C.3
Fleischmann, E.4
Schmieder, R.E.5
-
36
-
-
0034657482
-
Tacrolimus and myocardial hypertrophy
-
Nakata Y, Yoshibayashi M, Yonemura T, Uemoto S, Inomata Y, Tanaka K, Furusho K. Tacrolimus and myocardial hypertrophy. Transplantation 2000; 69:1960-1962.
-
(2000)
Transplantation
, vol.69
, pp. 1960-1962
-
-
Nakata, Y.1
Yoshibayashi, M.2
Yonemura, T.3
Uemoto, S.4
Inomata, Y.5
Tanaka, K.6
Furusho, K.7
-
37
-
-
0033922382
-
Cardiac and vascular abnormalities in renal transplant patients: Differential effects of cyclosporin and azathioprine
-
Galiatsou E, Morris ST, Jardine AG, Rodger RS, Watson MA, Elliott HL. Cardiac and vascular abnormalities in renal transplant patients: differential effects of cyclosporin and azathioprine. J Nephrol 2000; 13:185-192.
-
(2000)
J Nephrol
, vol.13
, pp. 185-192
-
-
Galiatsou, E.1
Morris, S.T.2
Jardine, A.G.3
Rodger, R.S.4
Watson, M.A.5
Elliott, H.L.6
-
38
-
-
19944428946
-
Stroke reduction in hypertensive adults with cardiac hypertrophy randomized to losartan versus atenolol: The Losartan Intervention For Endpoint reduction in hypertension study
-
Kizer JR, Dahlöf B, Kjeldsen SE, Julius S, Beevers G, de Faire U, Fyhrquist F, Ibsen H, Kristianson K, Lederballe-Pedersen O, Lindholm LH, Nieminen MS, Omvik P, Oparil S, Wedel H, Wachtell K, Edelman JM, Snapinn SM, Harris KE, Devereux RB. Stroke reduction in hypertensive adults with cardiac hypertrophy randomized to losartan versus atenolol: the Losartan Intervention For Endpoint reduction in hypertension study. Hypertension 2005; 45:46-52.
-
(2005)
Hypertension
, vol.45
, pp. 46-52
-
-
Kizer, J.R.1
Dahlöf, B.2
Kjeldsen, S.E.3
Julius, S.4
Beevers, G.5
de Faire, U.6
Fyhrquist, F.7
Ibsen, H.8
Kristianson, K.9
Lederballe-Pedersen, O.10
Lindholm, L.H.11
Nieminen, M.S.12
Omvik, P.13
Oparil, S.14
Wedel, H.15
Wachtell, K.16
Edelman, J.M.17
Snapinn, S.M.18
Harris, K.E.19
Devereux, R.B.20
more..
-
39
-
-
0035922695
-
Cardiovascular protection and blood pressure reduction: A meta-analysis
-
Staessen JA, Wang JG, Thijs L. Cardiovascular protection and blood pressure reduction: a meta-analysis. Lancet 2001; 358:1305-1315.
-
(2001)
Lancet
, vol.358
, pp. 1305-1315
-
-
Staessen, J.A.1
Wang, J.G.2
Thijs, L.3
-
40
-
-
38349129600
-
Effects of an ARB on endothelial progenitor cell function and cardiovascular oxidation in hypertension
-
Yu Y, Fukuda N, Yao EH, Matsumoto T, Kobayashi N, Suzuki R, Tahira Y, Ueno T, Matsumoto K. Effects of an ARB on endothelial progenitor cell function and cardiovascular oxidation in hypertension. Am J Hypertens 2008; 21:72-77.
-
(2008)
Am J Hypertens
, vol.21
, pp. 72-77
-
-
Yu, Y.1
Fukuda, N.2
Yao, E.H.3
Matsumoto, T.4
Kobayashi, N.5
Suzuki, R.6
Tahira, Y.7
Ueno, T.8
Matsumoto, K.9
-
41
-
-
0030295342
-
Can we use calcium antagonist better in antihypertensive therapy? Circadian consideration
-
Zhang W. Can we use calcium antagonist better in antihypertensive therapy? Circadian consideration. Pharmacol Res 1996; 34:187-191.
-
(1996)
Pharmacol Res
, vol.34
, pp. 187-191
-
-
Zhang, W.1
-
42
-
-
42049095708
-
Aggressive blood pressure control and stroke prevention: Role of calcium channel blockers
-
Papadopoulos DP, Papademetriou V. Aggressive blood pressure control and stroke prevention: role of calcium channel blockers. J Hypertens 2008; 26:844-852.
-
(2008)
J Hypertens
, vol.26
, pp. 844-852
-
-
Papadopoulos, D.P.1
Papademetriou, V.2
-
43
-
-
33644862589
-
Blood pressure-lowering effects of lifestyle modification: Possible involvement of nitric oxide bioavailability
-
Ohta M, Nanri H, Matsushima Y, Sato Y, Ikeda M. Blood pressure-lowering effects of lifestyle modification: possible involvement of nitric oxide bioavailability. Hypertens Res 2005; 28:779-786.
-
(2005)
Hypertens Res
, vol.28
, pp. 779-786
-
-
Ohta, M.1
Nanri, H.2
Matsushima, Y.3
Sato, Y.4
Ikeda, M.5
-
44
-
-
31944448854
-
Dietary approaches to prevent and treat hypertension: A scientific statement from the American Heart Association
-
Appel LJ, Brands MW, Daniels SR, Karanja N, Elmer PJ, Sacks FM. Dietary approaches to prevent and treat hypertension: a scientific statement from the American Heart Association. Hypertension 2006; 47:296-308.
-
(2006)
Hypertension
, vol.47
, pp. 296-308
-
-
Appel, L.J.1
Brands, M.W.2
Daniels, S.R.3
Karanja, N.4
Elmer, P.J.5
Sacks, F.M.6
-
45
-
-
0026643141
-
Identification of calcineurin as a key signalling enzyme in T-lymphocyte activation
-
Clipstone NA, Crabtree GR. Identification of calcineurin as a key signalling enzyme in T-lymphocyte activation. Nature 1992; 357:695-697.
-
(1992)
Nature
, vol.357
, pp. 695-697
-
-
Clipstone, N.A.1
Crabtree, G.R.2
-
46
-
-
33748923979
-
Hypertension and breast cancer: An association revisited?
-
Goon PK, Messerli FH, Lip GY. Hypertension and breast cancer: an association revisited? J Hum Hypertens 2006; 20:722-724.
-
(2006)
J Hum Hypertens
, vol.20
, pp. 722-724
-
-
Goon, P.K.1
Messerli, F.H.2
Lip, G.Y.3
-
47
-
-
0037120907
-
Primary prevention of hypertension: Clinical and public health advisory from The National High Blood Pressure Education Program
-
Whelton PK, He J, Appel LJ, Cutler JA, Havas S, Kotchen TA, Roccella EJ, Stout R, Vallbona C, Winston MC, Karimbakas J. Primary prevention of hypertension: clinical and public health advisory from The National High Blood Pressure Education Program. JAMA 2002; 288:1882-1888.
-
(2002)
JAMA
, vol.288
, pp. 1882-1888
-
-
Whelton, P.K.1
He, J.2
Appel, L.J.3
Cutler, J.A.4
Havas, S.5
Kotchen, T.A.6
Roccella, E.J.7
Stout, R.8
Vallbona, C.9
Winston, M.C.10
Karimbakas, J.11
-
48
-
-
0016763746
-
High blood-pressure: A risk factor for cancer mortality?
-
Dyer AR, Stamler J, Berkson DM, Lindberg HA, Stevens E. High blood-pressure: a risk factor for cancer mortality? Lancet 1975; 1:1051-1056.
-
(1975)
Lancet
, vol.1
, pp. 1051-1056
-
-
Dyer, A.R.1
Stamler, J.2
Berkson, D.M.3
Lindberg, H.A.4
Stevens, E.5
-
49
-
-
0141563692
-
Relation between use of antihypertensive medications and risk of breast carcinoma among women ages 65-79 years
-
Li CI, Malone KE, Weiss NS, Boudreau DM, Cushing-Haugen KL, Daling JR. Relation between use of antihypertensive medications and risk of breast carcinoma among women ages 65-79 years. Cancer 2003; 98:1504-1513.
-
(2003)
Cancer
, vol.98
, pp. 1504-1513
-
-
Li, C.I.1
Malone, K.E.2
Weiss, N.S.3
Boudreau, D.M.4
Cushing-Haugen, K.L.5
Daling, J.R.6
-
50
-
-
33748941768
-
Hypertension, diuretics and breast cancer risk
-
Largent JA, McEligot AJ, Ziogas A, Reid C, Hess J, Leighton N, Peel D, Anton-Culver H. Hypertension, diuretics and breast cancer risk. J Hum Hypertens 2006; 20:727-732.
-
(2006)
J Hum Hypertens
, vol.20
, pp. 727-732
-
-
Largent, J.A.1
McEligot, A.J.2
Ziogas, A.3
Reid, C.4
Hess, J.5
Leighton, N.6
Peel, D.7
Anton-Culver, H.8
-
52
-
-
34249908092
-
Immunosuppressive therapy and malignancy in organ transplant recipients: A systematic review
-
Gutierrez-Dalmau A, Campistol JM. Immunosuppressive therapy and malignancy in organ transplant recipients: a systematic review. Drugs 2007; 67:1167-1198.
-
(2007)
Drugs
, vol.67
, pp. 1167-1198
-
-
Gutierrez-Dalmau, A.1
Campistol, J.M.2
-
53
-
-
0031474406
-
Effects of calcium antagonist felodipine on renal sympathetic nerve activity in rats with congestive heart failure
-
Zhang W, Sun X, Zhao X, Thoren P, Hedner T. Effects of calcium antagonist felodipine on renal sympathetic nerve activity in rats with congestive heart failure. Cardiovasc Drugs Ther 1997; 11:645-650.
-
(1997)
Cardiovasc Drugs Ther
, vol.11
, pp. 645-650
-
-
Zhang, W.1
Sun, X.2
Zhao, X.3
Thoren, P.4
Hedner, T.5
-
54
-
-
0033033453
-
Brain renin-angiotensin system and sympathetic hyperactivity in rats after myocardial infarction
-
Zhang W, Huang BS, Leenen FH. Brain renin-angiotensin system and sympathetic hyperactivity in rats after myocardial infarction. Am J Physiol 1999; 276:H1608-H1615.
-
(1999)
Am J Physiol
, vol.276
-
-
Zhang, W.1
Huang, B.S.2
Leenen, F.H.3
-
55
-
-
0035843965
-
Resetting baroreceptors to a lower arterial pressure level by enalapril avoids baroreflex mediated activation of sympathetic nervous system by nifedipine
-
Zhang W, Wang Z. Resetting baroreceptors to a lower arterial pressure level by enalapril avoids baroreflex mediated activation of sympathetic nervous system by nifedipine. Life Sci 2001; 68:2769-2779.
-
(2001)
Life Sci
, vol.68
, pp. 2769-2779
-
-
Zhang, W.1
Wang, Z.2
|